Tyler Bussian
Stock Analyst at Brookline Capital
(0.18)
# 4,104
Out of 4,735 analysts
5
Total ratings
25%
Success rate
-28.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.52 | +492.11% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $2.18 | +2,789.91% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $0.95 | +952.63% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $5.22 | +72.41% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.52
Upside: +492.11%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $2.18
Upside: +2,789.91%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $0.95
Upside: +952.63%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $5.22
Upside: +72.41%